Article Details
Retrieved on: 2024-01-08 15:00:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche's Vabysmo that secured U.S. approval in 2022. Regeneron has set ... Eylea, jointly developed with Bayer AG, has driven Regeneron's earnings for ...
Article found on: www.aol.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here